These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23166734)

  • 1. CD95 is part of a let-7/p53/miR-34 regulatory network.
    Hau A; Ceppi P; Peter ME
    PLoS One; 2012; 7(11):e49636. PubMed ID: 23166734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
    Müller M; Wilder S; Bannasch D; Israeli D; Lehlbach K; Li-Weber M; Friedman SL; Galle PR; Stremmel W; Oren M; Krammer PH
    J Exp Med; 1998 Dec; 188(11):2033-45. PubMed ID: 9841917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U; Wagenknecht B; Naumann U; Weller M
    Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
    Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro(mi) RNA-34a targets protein phosphatase (PP)1γ to regulate DNA damage tolerance.
    Takeda Y; Venkitaraman AR
    Cell Cycle; 2015; 14(24):3830-41. PubMed ID: 26111201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
    Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
    Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of miR-605 and miR-34a in the DNA damage response promotes apoptosis induction.
    Zhou CH; Zhang XP; Liu F; Wang W
    Biophys J; 2014 Apr; 106(8):1792-800. PubMed ID: 24739178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34 and p53: New Insights into a Complex Functional Relationship.
    Navarro F; Lieberman J
    PLoS One; 2015; 10(7):e0132767. PubMed ID: 26177460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes.
    Mansoori B; Mohammadi A; Shirjang S; Baghbani E; Baradaran B
    Asian Pac J Cancer Prev; 2016; 17(4):1887-90. PubMed ID: 27221871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
    Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
    Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.
    Chen X; Yan J; Chen T
    Mol Carcinog; 2012 Aug; 51(8):674-7. PubMed ID: 21809390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.
    Li XL; Jones MF; Subramanian M; Lal A
    FEBS Lett; 2014 Aug; 588(16):2610-5. PubMed ID: 24726728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.
    Tarasov V; Jung P; Verdoodt B; Lodygin D; Epanchintsev A; Menssen A; Meister G; Hermeking H
    Cell Cycle; 2007 Jul; 6(13):1586-93. PubMed ID: 17554199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
    Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
    Samuel N; Wilson G; Id Said B; Pan A; Deblois G; Fischer NW; Alexandrova R; Casallo G; Paton T; Lupien M; Gariepy J; Merico D; Hudson TJ; Malkin D
    Oncotarget; 2016 Aug; 7(31):49611-49622. PubMed ID: 27391063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity.
    Tan J; Fan L; Mao JJ; Chen B; Zheng L; Zhang T; Li T; Duan J; Duan Y; Jin Z; Kuang W
    J Cell Biochem; 2012 Sep; 113(9):2903-8. PubMed ID: 22531959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.